| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | Nov 14, 2024 | ||
| SC 13G | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | AMENDMENT TO SC 13G | Feb 14, 2022 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 10, 2022 | |
| SC 13G/A | Report | HEPION PHARMACEUTICALS, INC. | Jan 19, 2022 | |
| SC 13G/A | Report | SABBY 13G-A HEPA 1.03.22 | Jan 4, 2022 | |
| SC 13G | Report | ACQUISITION OF BENEFICIAL OWNERSHIP | Feb 24, 2021 | |
| SC 13G | Report | SABBY 13G HEPA 2.19.21 | Feb 19, 2021 | |
| SC 13G | Report | HEPION PHARMACEUTICALS, INC. | Feb 18, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G | Report | SCHEDULE 13G | Feb 10, 2021 | |
| SC 13G/A | Report | HEPA 13GA | Feb 9, 2021 | |
| SC 13G/A | Report | HEPION PHARMACEUTICALS, INC. | Jan 20, 2021 | |
| SC 13G/A | Report | SABBY 13G-A HEPA 1.07.21 | Jan 7, 2021 | |
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Dec 28, 2020 | |
| SC 13G | Report | SCHEDULE 13G | Dec 9, 2020 | |
| SC 13G | Report | HEPION PHARMACEUTICALS, INC. | Dec 2, 2020 | |
| SC 13G | Report | SABBY 13G HEPA 12.01.20 | Dec 2, 2020 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2020 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2020 | |
| SC 13G | Report | HEPA 13G | Feb 5, 2020 | |
| SC 13G | Report | SC 13G | Jun 28, 2019 | |
| SC 13G | Report | SC 13G | Jun 27, 2019 | |
| SC 13G | Report | SC 13G | Apr 2, 2019 | |
| SC 13G | Report | NONE | Mar 18, 2019 | |
| SC 13G | Report | Mar 15, 2019 | ||
| SC 13G | Report | SC 13G | Jul 24, 2018 | |
| SC 13G | Report | SC 13G | Aug 17, 2016 | |
| SC 13G/A | Report | SC 13G/A | Feb 12, 2016 | |
| SC 13G/A | Report | CONTRAVIR PHARMACEUTICALS, INC. | Jan 19, 2016 | |
| SC 13G | Report | SC 13G | Oct 15, 2015 | |
| SC 13G | Report | EMPERY ASSET MANAGEMENT, LP | Oct 14, 2015 |